The molecular diagnostics laboratory processed approximately 900 unique clinical samples in 2007, accounting for over 3000 tests. Approximately 300 additional tests were performed to support a variety of translational research projects, for NCI/NIH PIs. The majority of the laboratory's tests are conventional PCR assays, including both DNA and RT-PCR assays. The assays performed by the molecular diagnostics laboratory include assays for B and T-cell clonality, assays for lymphoma related translocations, assays for cancer associated viruses (EBV, HTLV, HHV-8), and RT-PCR assays for translocations associated with pediatric sarcomas. Quantitative PCR is performed for HTLV 1/2 to follow viral load for the Metabolism Branch's ATL clinical trials. Assays are performed on materials derived from a variety of sources. Paraffin fixed tissue specimens account for about 60% of the samples and blood, 30%. The remaining 10% of samples are derived from fresh or frozen tissue, cerebrospinal fluid, and other body fluids. A high percentage of the paraffin section studies are complex and labor intensive, requiring macro or microdissection of specific components of lesional tissues, and are performed under the guidance of a fellow or staff pathologist. The molecular laboratory is particularly expert in extracting nucleic acids from small fragments of archival paraffin-embedded tissues, and our expertise in this area has been widely sought out in a number of laboratories within and outside of NIH. The laboratory maintains 3 Perkin-Elmer 9700 PCR platforms, one ABI 7900 real-time PCR machine, and one ABI 3130 capillary electrophoresis unit. As part of the recent funding initiative to expand molecular diagnostics testing in the LP, the laboratory just purchased a Pyromark 2400 pyrosequencer which will be employed initially for K-RAS mutation analysis, and for MGMT promoter methylation analysis. The molecular diagnostics laboratory supports translational research of both NCI and NIH researchers. Among the NCI and NIH tenured investigators and clinicians that have utilized the laboratory's resources and data to support their publications are: Dr. Elaine Jaffe (NCI) Dr. Maria Tsokos (NCI) Dr. Andrea Abati (NCI) Dr. Robert Kreitman (NCI) Dr. Wyndham Wilson (NCI) Dr. John Janik (NCI) Dr. John Morris (NCI) Dr. Steven Holland (NIAID) Dr, Richard Little (NCI) Dr. Dean Metcalfe (NIAID) Dr. Amy Klion Dr. John Morris

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC011079-01
Application #
7733475
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2008
Total Cost
$1,422,634
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Thomas, Anish; Xi, Liqiang; Carter, Corey A et al. (2013) Concurrent molecular alterations in tumors with germ line epidermal growth factor receptor T790M mutations. Clin Lung Cancer 14:452-6
Ritchie, David; Piekarz, Richard L; Blombery, Piers et al. (2009) Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report. Haematologica 94:1618-22
Morovic, Anamarija; Jaffe, Elaine S; Raffeld, Mark et al. (2009) Metachronous EBV-associated B-cell and T-cell posttransplant lymphoproliferative disorders in a heart transplant recipient. Am J Surg Pathol 33:149-54
O'Mahony, Deirdre; Morris, John C; Stetler-Stevenson, Maryalice et al. (2009) EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignancies. Clin Cancer Res 15:2514-22
Mao, Zhengrong; Quintanilla-Martinez, Leticia; Raffeld, Mark et al. (2007) IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Am J Surg Pathol 31:1605-14
Hardy, Nancy M; Grady, Christine; Pentz, Rebecca et al. (2007) Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation. Br J Haematol 139:824-31
Manosca, Frances; Schinstine, Malcolm; Fetsch, Patricia A et al. (2007) Diagnostic effects of prolonged storage on fresh effusion samples. Diagn Cytopathol 35:6-11